This safety study investigates seizure rates in men at increased risk for seizure who are taking enzalutamide for metastatic castration-resistant prostate cancer.
http://ift.tt/2j3eiDF
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: Available online 22 March 2017 Source: Vaccine Author(s): Yanli Yang, Qizu Zhao, Zhengjun Li, Lijing Sun, Guanghui Ma,...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου